Trump Plans 100% Tariff on Generic Drugs From 2028
President Donald Trump said generic drug manufacturers will have two years to move production to the US or face a 100% import duty. Bloomberg's Mica Soellner reports on what could come next.
President Donald Trump said generic drug manufacturers will have two years to move production to the US or face a 100% import duty. Bloomberg's Mica Soellner reports on what could come next.
Battery Age Minerals (ASX:BM8) completed staking for an additional 9km2 of contiguous mineral claims at its Falcon Lake Project.
Origin Energy (ASX:ORG) is investigating a potential security incident that may involve unauthorised access to customer data.
Financial services provider Praemium (ASX:PPS) increased its total funds under administration by 21.1% to $77.9 billion.
MONEYME (ASX:MME) grew its total loan book past $1.23 billion in annual loan originations.
Brazilian Rare Earths (ASX:BRE) secured $50 million through the maximum subscription initial public offering of spin-off entity Alurion Resources.
Horizon Gold (ASX:HRN) has released a definitive feasibility study setting a pathway to start gold production at its Gum Creek Project.
Peninsula Energy (ASX:PEN) has withdrawn its 2026 production guidance following wellfield ramp-up delays at the Lance Uranium Project.
Medallion Metals (ASX:MM8) signed a term sheet with TG Metals (ASX:TG6) to process 60kt of gold material and share pre-tax profits.
Regal Partners (ASX:RPL) expects its first-half net profit to double to at least $90 million.
AustralianSuper plans to double its private credit exposure to near $20 billion within four years
Stockland (ASX:SGP) has appointed Robert Johnston as the incoming chairman of the board, effective Oct. 19.